DexCom (DXCM) Soars 10% This Week: What's Fueling the Gain?

Shares of DexCom (DXCM) have gained almost 10% so far this week compared to its closing last Friday. The strong rally in the company’s share price can be attributed to the recent FDA approval of its first glucose biosensor, Stelo, which will provide glucose insights directly to a user’s smartphone. Moreover, the availability of the sensor over-the-counter to consumers without a prescription is likely to broaden Dexcom’s targeted patient population.Stelo is likely to be available for purchase online without ...